rss
Br J Sports Med 2006;40:i40-i42 doi:10.1136/bjsm.2006.027490

Therapeutic use exemption

  1. J Dvorak1,
  2. D Kirkendall2,
  3. M Vouillamoz3
  1. 1FIFA Medical Assessment and Research Centre, and Department of Neurology, Schulthess Clinic, Zurich, Switzerland
  2. 2FIFA Medical Research and Assessment Centre, and Department of Orthopaedics, University of North Carolina, Chapel Hill, NC, USA
  3. 3UEFA Anti Doping Unit, Nyon, Switzerland
  1. Correspondence to:
 Professor J Dvorak
 Chairman, FIFA Medical Assessment and Research Centre, Department of Neurology, Schulthess Clinic, Lengghalde 2, 8008 Zurich, Switzerland; jiri.dvorak{at}kws.ch

    Abstract

    Football players who have either physical symptoms or disease after injury may need to be treated with specific medicines that are on the list of prohibited substances. Therapeutic use exemption may be granted to such players, in accordance with strictly defined criteria—these are presented in this article. Procedures of how to request for an abbreviated or a standard therapeutic use exemption are explained, and data on therapeutic use exemptions (UEFA and FIFA, 2004 and 2005) are also presented.

    Footnotes

    • Competing interests: None declared

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.